Argenx
ARGX
#584
Rank
โ‚น3.007 T
Marketcap
โ‚น50,288
Share price
0.77%
Change (1 day)
23.43%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total assets

Total assets on the balance sheet as of June 2024 : โ‚น404.70 Billion

According to Argenx 's latest financial reports the company's total assets are โ‚น404.70 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Argenx - Total assets on balance sheet (from 2021 to 2020)

Total assets by year

Year Total assets Change
2022-12-31โ‚น259.36 B22.25%
2021-12-31โ‚น212.14 B3.47%
2020-12-31โ‚น205.04 B59.4%
2019-12-31โ‚น128.63 B143.02%
2018-12-31โ‚น52.93 B55.26%
2017-12-31โ‚น34.09 B328.74%
2016-12-31โ‚น7.95 B117.77%
2015-12-31โ‚น3.65 B-33.42%
2014-12-31โ‚น5.48 B86.1%
2013-12-31โ‚น2.94 B77.45%
2012-12-31โ‚น1.66 B-24.32%
2011-12-31โ‚น2.19 B200.26%
2010-12-31โ‚น0.73 B